0001493152-21-009387.txt : 20210421
0001493152-21-009387.hdr.sgml : 20210421
20210421165520
ACCESSION NUMBER: 0001493152-21-009387
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210416
FILED AS OF DATE: 20210421
DATE AS OF CHANGE: 20210421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Uzonwanne Jude
CENTRAL INDEX KEY: 0001858040
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36268
FILM NUMBER: 21842284
MAIL ADDRESS:
STREET 1: C/O AKERS BIOSCIENCES, INC.
STREET 2: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001321834
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 856-848-8698
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences, Inc.
DATE OF NAME CHANGE: 20170413
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences Inc
DATE OF NAME CHANGE: 20050325
4
1
ownership.xml
X0306
4
2021-04-16
0
0001321834
MyMD Pharmaceuticals, Inc.
MYMD
0001858040
Uzonwanne Jude
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK,
NY
10036
1
0
0
0
Stock Option (Right to Buy)
2.5913
2021-04-16
4
A
0
115770
A
2023-04-16
Common Stock
115770
115770
D
Received in exchange for a stock option to acquire 300,000 shares of common stock of a private company formerly known as "MyMD Pharmaceuticals, Inc." (the "Former Entity") at $1.00 per share in connection with the merger of the Former Entity with and into a wholly owned subsidiary of the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share.
The shares underlying this stock option shall vest according to the following schedule: 50% on October 26, 2021 and 50% on October 26, 2022.
/s/ Jude Uzonwanne
2021-04-21